ArticleStatistics in biopharmaceutical research2022

Accuracy and Safety of Novel Designs for Phase I Drug-Combination Oncology Trials.

Rong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.